KalVista Pharmaceuticals, Inc. logo

KalVista Pharmaceuticals, Inc.

NASDAQ:KALV

Overview | Financials
Company Name KalVista Pharmaceuticals, Inc.
Symbol KALV
Currency USD
Price 12.34
Market Cap 531,630,646
Dividend Yield 0%
52-week-range 7.21 - 16.88
Industry Biotechnology
Sector Healthcare
CEO Mr. Thomas Andrew Crockett M.B.A.
Website https://www.kalvista.com

An error occurred while fetching data.

About KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a

Related Stocks

Cogent Biosciences, Inc. logo

Cogent Biosciences, Inc.

COGT

10.47 USD

VistaGen Therapeutics, Inc. logo

VistaGen Therapeutics, Inc.

VTGN

3.25 USD

VBI Vaccines Inc. logo

VBI Vaccines Inc.

VBIV

0.065 USD

Zentek Ltd. logo

Zentek Ltd.

ZTEK

1.25 USD

Prelude Therapeutics Incorporated logo

Prelude Therapeutics Incorporated

PRLD

4.85 USD

bluebird bio, Inc. logo

bluebird bio, Inc.

BLUE

0.529 USD

Viemed Healthcare, Inc. logo

Viemed Healthcare, Inc.

VMD

7.33 USD

MacroGenics, Inc. logo

MacroGenics, Inc.

MGNX

3.25 USD

Singular Genomics Systems, Inc. logo

Singular Genomics Systems, Inc.

OMIC

5.892 USD

PepGen Inc. logo

PepGen Inc.

PEPG

8.83 USD

Financials

Numbers are in millions USD

Numbers are in millions USD